Inhibition of sorcin reverses multidrug resistance of K562/A02 cells and MCF-7/A02 cells via regulating apoptosis-related proteins

Cancer Chemotherapy and Pharmacology

Volumn 72, Issue 4, 2013, Pages 789-798

  Hu, Yunhui ^a,b   Cheng, Xin ^a,c   Li, Shuangjing ^a   Zhou, Yuan ^a   Wang, Jianxiang ^a   Cheng, Tao ^a   Yang, Ming ^a   Xiong, Dongsheng ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c INSTITUTE OF ZOOLOGY   (China)

Author keywords

Apoptosis; Multidrug resistance; P gp; Sorcin

Indexed keywords

DOXORUBICIN; ETOPOSIDE; HOMOHARRINGTONINE; MESSENGER RNA; MITOXANTRONE; MULTIDRUG RESISTANCE PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN C FOS; PROTEIN C JUN; SMALL INTERFERING RNA; SORCIN; VERAPAMIL; VINCRISTINE;

APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER RESISTANCE; CELL STRAIN K 562; CELL STRAIN MCF 7; CELL SURVIVAL; CHEMOSENSITIVITY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; INHIBITION KINETICS; LEUKEMIA CELL; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SORCIN GENE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CALCIUM-BINDING PROTEINS; CELL SURVIVAL; DOWN-REGULATION; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE SILENCING; HUMANS; K562 CELLS; LEUKEMIA; MCF-7 CELLS; P-GLYCOPROTEIN; RNA, SMALL INTERFERING;

EID: 84885379196     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-013-2254-2     Document Type: Article

References (34)

1. Gottesman MM, Fojo T, Bates SE (2002) Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2(1):48-58
2. Steinbach D, Legrand O (2007) ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra? Leukemia 21(6):1172-1176
3. Liu F et al (2008) Co-expression of cytokeratin 8 and breast cancer resistant protein indicates a multifactorial drug-resistant phenotype in human breast cancer cell line. Life Sci 83(13-14):496-501
4. Wang CH et al (2009) Effects of non-cytotoxic drugs on the growth of multidrug-resistance human gastric carcinoma cell line. J Dig Dis 10(2):91-98
5. Zhao LJ et al (2012) Modulation of drug resistance in ovarian cancer cells by inhibition of protein kinase C-alpha (PKC-alpha) with small interference RNA (siRNA) agents. Asian Pac J Cancer Prev 13(8):3631-3636
6. Ye CG et al (2011) Indomethacin and SC236 enhance the cytotoxicity of doxorubicin in human hepatocellular carcinoma cells via inhibiting P-glycoprotein and MRP1 expression. Cancer Lett 304(2):90-96
7. Pu J, Lou F, Zhou Q (1999) In vitro reversal effect of cyclosporin A in combination with cytokines on multidrug resistant cell line K562/A02. Zhonghua Yi Xue Za Zhi 79(3):224-226
8. Meyers MB et al (1995) Association of sorcin with the cardiac ryanodine receptor. J Biol Chem 270(44):26411-26418
9. Hamada H et al (1988) Purification of the Mr 22,000 calcium-binding protein (sorcin) associated with multidrug resistance and its detection with monoclonal antibodies. Cancer Res 48(11):3173-3178
10. Roberts D et al (1989) Association of sorcin with drug resistance in L1210 cells. Cancer Chemother Pharmacol 23(1):19-25
11. Parekh HK et al (2002) Overexpression of sorcin, a calcium-binding protein, induces a low level of paclitaxel resistance in human ovarian and breast cancer cells. Biochem Pharmacol 63(6):1149-1158
12. He QC, Zhang GY, Cao WJ (2008) Correlation of sorcin overexpression to multidrug resistance of human gastric cancer cell line SGC7901. Ai Zheng 27(4):337-342
13. Qu Y et al (2010) Comparative proteomic profiling identified sorcin being associated with gemcitabine resistance in non-small cell lung cancer. Med Oncol 27(4):1303-1308
14. Nagpal JK, Das BR (2007) Identification of differentially expressed genes in tobacco chewing-mediated oral cancer by differential display-polymerase chain reaction. Eur J Clin Invest 37(8):658-664
15. Tan Y et al (2003) Expression of sorcin predicts poor outcome in acute myeloid leukemia. Leuk Res 27(2):125-131
16. Zhou Y et al (2006) Sorcin, an important gene associated with multidrug-resistance in human leukemia cells. Leuk Res 30(4):469-476
17. Yang CZ et al (1995) Multidrug resistance in leukemic cell line K562/A02 induced by doxorubicin. Zhongguo Yao Li Xue Bao 16(4):333-337
18. Shi R et al (2011) A novel indirubin derivative PHII-7 potentiates adriamycin cytotoxicity via inhibiting P-glycoprotein expression in human breast cancer MCF-7/ADR cells. Eur J Pharmacol 669(1-3):38-44
19. Batist G et al (1986) Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J Biol Chem 261(33):15544-15549
20. Qi J et al (2002) Function and mechanism of pyronaridine: a new inhibitor of P-glycoprotein-mediated multidrug resistance. Acta Pharmacol Sin 23(6):544-550
21. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65(1-2):55-63
22. Yague E et al (2003) P-glycoprotein (MDR1) expression in leukemic cells is regulated at two distinct steps, mRNA stabilization and translational initiation. J Biol Chem 278(12):10344-10352
23. Hwang M, Moretti L, Lu B (2009) HSP90 inhibitors: multi-targeted antitumor effects and novel combinatorial therapeutic approaches in cancer therapy. Curr Med Chem 16(24):3081-3092
24. Kellner U et al (1997) Decreased drug accumulation in a mitoxantrone-resistant gastric carcinoma cell line in the absence of P-glycoprotein. Int J Cancer 71(5):817-824
25. Beyer-Sehlmeyer G et al (1999) Suppressive subtractive hybridisation reveals differential expression of serglycin, sorcin, bone marrow proteoglycan and prostate-tumour-inducing gene I (PTI-1) in drug-resistant and sensitive tumour cell lines of haematopoetic origin. Eur J Cancer 35(12):1735-1742
26. Kawakami M et al (2007) Knock-down of sorcin induces up-regulation of MDR1 in HeLa cells. Biol Pharm Bull 30(6):1065-1073
27. Wang SL et al (1995) Isolation and molecular cloning of human sorcin a calcium-binding protein in vincristine-resistant HOB1 lymphoma cells. Biochim Biophys Acta 1260(3):285-293
28. Lee WP (1996) Purification, cDNA cloning, and expression of human sorcin in vincristine-resistant HOB1 lymphoma cell lines. Arch Biochem Biophys 325(2):217-226
29. Landriscina M et al (2010) Mitochondrial chaperone Trap1 and the calcium binding protein sorcin interact and protect cells against apoptosis induced by antiblastic agents. Cancer Res 70(16):6577-6586
30. Mikula M et al (2003) The proto-oncoprotein c-Fos negatively regulates hepatocellular tumorigenesis. Oncogene 22(43):6725-6738
31. Herrlich P (2001) Cross-talk between glucocorticoid receptor and AP-1. Oncogene 20(19):2465-2475
32. Deng L et al (2010) Upregulation of soluble resistance-related calcium-binding protein (sorcin) in gastric cancer. Med Oncol 27(4):1102-1108
33. Maddalena F et al (2013) Resistance to paclitxel in breast carcinoma cells requires a quality control of mitochondrial antiapoptotic proteins by TRAP1. Mol Oncol. pii: S1574-7891(13)00079-3
34. Diaz-Blanco E et al (2007) Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase. Leukemia 21(3):494-504